Canadian manufacturer is getting ready to launch Reveal™, enabling bone and tissue differentiation without motion artifacts
Canadian manufacturer KA Imaging is preparing to launch Reveal, a premium x-ray detector that upgrades any x-ray system to Dual-Energy. “Reveal is the ideal retrofit solution as it will fit into any ISO standard size tray”, explains Amol Karnick, president and CEO of KA Imaging. Thanks to this feature, the cost of implementation can be reduced to a fraction of the price: whereas conventional dual exposure dual-energy systems can cost as high as half a million dollars, KA Imaging’s Reveal can be obtained at a quarter of this price. “You can simply replace your old detector with Reveal, as it will work with any conventional portable or fixed x-ray source”, continues Amol.
The competitive pricing strategy is just one of the advantages. KAI developed a unique technology that can improve dual-energy x-ray images. Reveal is the world’s first portable digital detector capable of separating different energy levels with a single exposure. It delivers three images: traditional DR, soft tissue and bone. “Our patented technology eliminates the motion artifact problem often seen in traditional dual exposure dual-energy X-Ray imaging systems”, explains Dr. Karim S Karim, CTO at KA Imaging. According to Karim, the detector simultaneously enables DR images with very high DQE (detective quantum efficiency) allowing for low radiation exposures to the patient and excellent quality soft tissue and bone images.
The Reveal detector has been used clinically on more than 20 patients with lung cancer. The clinical trial is being held at Grand River Hospital in Kitchener, Ontario and is expected to scan up to 30 patients.
Reveal is being submitted to the US FDA for clearance in 2020. Radiologists globally can learn more about Reveal at the European Congress of Radiology (ECR) between March 11th to 15th at the Austria Center Vienna. KA Imaging is exhibiting at booth #G41.
ECR is one of the largest medical meetings in Europe. Canada is a featured country at this event. “We are proud that as a partner country, we are able to present Canadian technology at this year’s ECR” says Stéphane Charbonneau, Consul and Senior Trade Commissioner at the Embassy of Canada in Vienna.
Did you know KA Imaging has a Quality Policy?
At KA Imaging, we are committed to the design and development of x-ray systems that meet the needs of our customers. Through the implementation of our quality processes, we will comply with all applicable regulatory requirements and maintain the effectiveness of
the Quality Management System. We build quality in all we do.
Therefore, at KA Imaging, quality is everybody’s business! It is a journey of continuous improvement. The question is: how do you achieve quality?
Quality is defined as Conformance to Requirements. That is, any product, service, or process that conforms to its requirements is a Quality Product, Service, or Process.
At KA Imaging, ‘Quality’ is based upon Process Management and Improvement Methodology (PM&I). It focuses upon Processes and their efficiencies that produce their outcomes in a consistent and a repeatable manner. The Process Outcomes must meet their agreed upon requirements. The pictorial view below represents KA Imaging’s PM&I model.
For KA Imaging to function effectively, it has identified and has linked all business processes. The application of a system of processes within an organization, together with the identification and interactions of these processes and their management to produce the desired outcome, can be referred to as the “process approach”. The linking of the processes to produce outcomes is also known as inter-related processes.
KA Imaging deploys a RASUI concept in its approach towards designing and developing products. RASUI is an acronym that stands for ‘Reliability, Availability, Serviceability, Usability, and Installability’.
KA Imaging being in the business of Development and Manufacturing of medical devices such as high-end Dual-Energy X-Ray Detectors, it is crucial that it consistently meets the ISO 13485:2016 Standard and Regulatory requirements. To this end, KA Imaging engages in training all its employees in the Process based Quality Management System including Management.
2020 heralds a year of change for KA Imaging.
For starters, the office in Kitchener (Ontario, Canada) became restrictive as the team expanded at an unprecedented rate—with three times more jobs created in 2019 than the year before. As a result, KA Imaging moved to a new location, a spacious 9,000 square-foot newly-renovated facility in Waterloo.
The office, however, is the smallest of the changes expected. “After almost 5 years of extensive development, we are starting to commercialize our line of products,” Amol Karnick, president and CEO at KA Imaging says. “Our focus is on our customers; what they need and how we can help.”
With an ambitious product and technology roadmap, the company is now developing strategic partnerships across the world. One example is the exclusive distribution agreement for KAI’s inline benchtop micro-CT system inCiTe™ with Angstrom Scientific Inc. (USA). InCiTe™ offers revolutionary phase contrast micro-CT imaging and is ideal for use on biomaterials, polymer composites and other low-density materials.
On the medical imaging side, KAI’s dual-energy single exposure X-ray detector Reveal must be submitted for FDA clearance this year.
KA Imaging is a University of Waterloo spin-off and has scaled rapidly since inception. The company aims to establish itself as a major player in the X-ray detector industry. “It’s been a long journey for us. Our team has worked hard to strengthen our patent portfolio. We now have over 50 patents worldwide and plan to continue developing disruptive x-ray tech over the next years,’ concludes Dr. Karim S Karim, CTO at KA Imaging.
“We set a number of very ambitious, stretch goals for 2019 and incredibly, accomplished most of them”, said Dr. Karim S Karim, CTO at KA Imaging. “I’m very happy and proud of the entire KA family and how well they work with and support each other”, he continued.
A family that has continuously grown. In 2019, 10 new people joined KA Imaging, sharing their expertise in different areas, such as Engineering, Finance and Business Development. The number of employees is now 58% higher than in 2016. “We have a great team of dedicated people who are interested in learn and developing good products”, explained Amol Karnick, CEO at KAI. “The team has grown this year to included additional skill set including hardware and software design”, he said.
A year to celebrate
2019 was full of highlights. The company exhibited at 6 conferences and visited several others, having traveled more than 10,000 km around the globe.
KA Imaging’s inCiTe™ micro CT had its commercialization started and the first unit was delivered at the National Research Council Canada. At MRS, the technology was introduced to researchers, along with BrillianSe™, the world’s highest spatial resolution direct conversion X-ray detector for hard X-ray. Christopher Scott, an engineer leading the inCiTe™ and BrillianSe™ product development, had a poster presentation to talk about the technology.
The dual-energy single exposure flat panel detector Reveal™ was launched at RSNA and has sparked interest in the industry. Engineer Sebastian Maurino had a talk during the conference and gave more details about the technology. Representing KA Imaging, his abstract received the Roadie Award from AuntMinnie. “Our clinical trial with patient data has been excellent as well as it shows tangibly the benefits of KA Imaging’s efforts”, celebrated Dr. Karim.
Angstrom Scientific Inc. is appointed as exclusive US distributor for the phase-contrast benchtop inCiTe™ micro-CT
Kitchener (Ontario, Canada) –KA Imaging has signed an exclusive distribution agreement for the USA with Angstrom Scientific Inc. for its phase-contrast benchtop inCiTe™ micro-CT system. inCiTe™ is a revolutionary benchtop micro-CT system capable of inline phase-contrast.
Canadian manufacturer KA Imaging has managed to overcome the challenge of having soft-tissue differentiation and single exposure featured in the same digital X-ray detector. The company plans to present Reveal™ to the Health Care market next year.